‘252 TB cases diagnosed as multi-drug resistant’

February 09, 2013 02:52 pm | Updated 02:52 pm IST - VISAKHAPATNAM:

Facilities at the Culture and Drug Susceptibility Testing Laboratory at the Government Hospital for Chest and Communicable Diseases will be improved further, said its Superintendent P. Subba Rao while participating in the inaugural session of a pre-continuing medical education (CME) programme of the 16 annual conference of State chapter of Indian Association of Medical Microbiologists here on Friday.

The laboratory, which is more than a year old, is conducting line probe assay (LPA) and providing results of the test done on sputum sample within 72 hours. At present it is conducting tests on solid culture and would soon have facility to do tests on liquid culture.

Principal of Andhra Medical College N. Kalpana Subrahmanyam inaugurated the CME and appreciated the Department of Microbiology for organising the CME and the two-day State conference from Saturday.

District TB Control Officer B. Sashidhar Kumar informed that 252 cases were diagnosed as multi-drug resistant (MDR) TB in the district. HoD of Microbiology and organising secretary I. Jyothi Padmaja presided.

The CME was jointly conducted by Department of Pulmonology of GHCCD and State chapter of IAMM, on the theme, LPA for MDR TB. Delegates from several medical colleges across the State attended.

Dr. Rahul Narang of Foundation for Innovative New Diagnostics (FIND) explained about LPA and conducted a demonstration which was relayed live on CCTV from the CDST Lab.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.